Wet Age Related Macular Degeneration (AMD) Market Report

Global and Region Wet Age Related Macular Degeneration (AMD) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：212
  • REPORT CODE：GMM930245
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.

    The report details the trend, potential and market size of Wet Age Related Macular Degeneration (AMD) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Wet Age Related Macular Degeneration (AMD)market, defines the market attractiveness level of Wet Age Related Macular Degeneration (AMD) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Wet Age Related Macular Degeneration (AMD) industry, describes the types of Wet Age Related Macular Degeneration (AMD) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Wet Age Related Macular Degeneration (AMD) market and the development prospects and opportunities of Wet Age Related Macular Degeneration (AMD) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Wet Age Related Macular Degeneration (AMD) market in Chapter 13.

    By Player:

    • Alimera Sciences Inc

    • Ophthotech Corporation

    • Bayer AG

    • Novartis AG

    • Kubota Pharmaceutical Holdings Co Ltd

    • Gilead Sciences Inc

    • Regeneron Pharmaceuticals Inc

    • F Hoffmann-La Roche Ltd (Roche)

    • Neurotech Pharmaceuticals Inc

    By Type:

    • Lucentis

    • Eylea

    • Avastin

    By End-User:

    • Hospitals and Clinics

    • Research and Academic Institute

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Wet Age Related Macular Degeneration (AMD) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Wet Age Related Macular Degeneration (AMD) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Wet Age Related Macular Degeneration (AMD) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Wet Age Related Macular Degeneration (AMD) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Wet Age Related Macular Degeneration (AMD) Market Analysis and Outlook to 2022

    • 7.1 Global Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)

    • 7.2 United States Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)

    • 7.3 Europe Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)

    • 7.4 China Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)

    • 7.5 Japan Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)

    • 7.6 India Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)

    • 7.7 South Korea Wet Age Related Macular Degeneration (AMD) Consumption (2017-2022)

    8 Region and Country-wise Wet Age Related Macular Degeneration (AMD) Market Analysis and Outlook to 2028

    • 8.1 Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)

    • 8.2 United States Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)

    • 8.3 Europe Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)

    • 8.4 China Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)

    • 8.5 Japan Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)

    • 8.6 India Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)

    • 8.7 South Korea Wet Age Related Macular Degeneration (AMD) Consumption Forecast (2022-2028)

    9 Global Wet Age Related Macular Degeneration (AMD) Market Outlook by Types and Applications to 2022

    • 9.1 Global Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Lucentis Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Eylea Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Avastin Consumption and Growth Rate (2017-2022)

    • 9.2 Global Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research and Academic Institute Consumption and Growth Rate (2017-2022)

    10 Global Wet Age Related Macular Degeneration (AMD) Market Outlook by Types and Applications to 2028

    • 10.1 Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Lucentis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Eylea Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Avastin Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research and Academic Institute Consumption Forecast and Growth Rate (2022-2028)

    11 Global Wet Age Related Macular Degeneration (AMD) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Wet Age Related Macular Degeneration (AMD) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Wet Age Related Macular Degeneration (AMD) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Wet Age Related Macular Degeneration (AMD) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Wet Age Related Macular Degeneration (AMD) Market Competitive Analysis

    • 14.1 Alimera Sciences Inc

      • 14.1.1 Alimera Sciences Inc Company Details

      • 14.1.2 Alimera Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Alimera Sciences Inc Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.2 Ophthotech Corporation

      • 14.2.1 Ophthotech Corporation Company Details

      • 14.2.2 Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.3 Bayer AG

      • 14.3.1 Bayer AG Company Details

      • 14.3.2 Bayer AG Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.4 Novartis AG

      • 14.4.1 Novartis AG Company Details

      • 14.4.2 Novartis AG Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis AG Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.5 Kubota Pharmaceutical Holdings Co Ltd

      • 14.5.1 Kubota Pharmaceutical Holdings Co Ltd Company Details

      • 14.5.2 Kubota Pharmaceutical Holdings Co Ltd Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Kubota Pharmaceutical Holdings Co Ltd Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.6 Gilead Sciences Inc

      • 14.6.1 Gilead Sciences Inc Company Details

      • 14.6.2 Gilead Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Gilead Sciences Inc Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.7 Regeneron Pharmaceuticals Inc

      • 14.7.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.7.2 Regeneron Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Regeneron Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.8 F Hoffmann-La Roche Ltd (Roche)

      • 14.8.1 F Hoffmann-La Roche Ltd (Roche) Company Details

      • 14.8.2 F Hoffmann-La Roche Ltd (Roche) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 F Hoffmann-La Roche Ltd (Roche) Wet Age Related Macular Degeneration (AMD) Product and Service

    • 14.9 Neurotech Pharmaceuticals Inc

      • 14.9.1 Neurotech Pharmaceuticals Inc Company Details

      • 14.9.2 Neurotech Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Neurotech Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Wet Age Related Macular Degeneration (AMD)

    • Figure Wet Age Related Macular Degeneration (AMD) Picture

    • Table Global Wet Age Related Macular Degeneration (AMD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Wet Age Related Macular Degeneration (AMD) Consumption by Country (2017-2022)

    • Figure United States Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)

    • Table Europe Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)

    • Figure China Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)

    • Figure Japan Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)

    • Figure India Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Wet Age Related Macular Degeneration (AMD) Consumption and Growth Rate (2017-2022)

    • Figure Global Wet Age Related Macular Degeneration (AMD) Consumption Forecast by Country (2022-2028)

    • Figure United States Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Wet Age Related Macular Degeneration (AMD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lucentis Consumption and Growth Rate (2017-2022)

    • Figure Global Eylea Consumption and Growth Rate (2017-2022)

    • Figure Global Avastin Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals and Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research and Academic Institute Consumption and Growth Rate (2017-2022)

    • Figure Global Lucentis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eylea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals and Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research and Academic Institute Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Wet Age Related Macular Degeneration (AMD) Export by Region (Top 5 Countries) (2017-2028)

    • Table Alimera Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Alimera Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alimera Sciences Inc Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table Ophthotech Corporation (Foundation Year, Company Profile and etc.)

    • Table Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ophthotech Corporation Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table Kubota Pharmaceutical Holdings Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Kubota Pharmaceutical Holdings Co Ltd Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kubota Pharmaceutical Holdings Co Ltd Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table F Hoffmann-La Roche Ltd (Roche) (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd (Roche) Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Roche) Wet Age Related Macular Degeneration (AMD) Product and Service

    • Table Neurotech Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Neurotech Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurotech Pharmaceuticals Inc Wet Age Related Macular Degeneration (AMD) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US